<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03842644</url>
  </required_header>
  <id_info>
    <org_study_id>SH9H-2018-T65-2</org_study_id>
    <nct_id>NCT03842644</nct_id>
  </id_info>
  <brief_title>Postoperative Skin Surface Tension Relaxing in Prevention of Facial Surgical Skin Scarring</brief_title>
  <official_title>Postoperative Skin Surface Tension Relaxing in Prevention of Facial Surgical Skin Scarring: a Single Center, Perspective, Randomly, Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>XiaoXi Lin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of early postoperative skin
      surface reduction in improving scar formation after facial surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary measurement: the mean scar width calculated by standard photos with rulers.

      Secondary measure: the probability of scar hyperplasia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 16, 2019</start_date>
  <completion_date type="Anticipated">January 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Scar width</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>scar width is measure by standard photo with ruler</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hypertrophic scar rate</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>The onset of hypertrophic scar will be documented in the time of follow-up. The red and stiffness scar which higher than the surrounding skin surface will be considered as hypertrophic scar.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient and observer scar assessment scale score</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Subscale 1: observer scar assessment scale (score range 5-50), the score 50 is considered as the worse outcome.
Subscale 2: patient scar assessment scale (score range 5-50), the score 50 is considered as the worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vancouver Scar Scale</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>total score range from 0 to 14, the score14 is considered as the worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative side effect</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>The relative side effect will be documented in each time of follow-up.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Scar</condition>
  <arm_group>
    <arm_group_label>Tension Reduction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tension reduction device for 3 months post surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No tension reduction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tension reduction device</intervention_name>
    <description>Continue using this device for 3 months post surgery.</description>
    <arm_group_label>Tension Reduction</arm_group_label>
    <other_name>Zipline Surgical Skin Closure Device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The incision is not shorter than 3cm

          -  Skin type is III/IV

        Exclusion Criteria:

          -  Any medical history of facial surgery, not included injection therapy, external
             medication or fat graft

          -  Unsuitable for device use due to anatomical location of incision, eg. lips, eyelids
             and ear

          -  Patients with a history of keloid or family history of keloid

          -  Patients with serious skin disorders, eg. serious psoriasis or dermatitis

          -  Patients with severe systemic or congenital disease which may affect the patient's
             safety in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lin, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lin, PhD</last_name>
    <phone>021-23271699</phone>
    <phone_ext>5576</phone_ext>
    <email>linxiaoxi@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chen, PhD</last_name>
    <phone>021-23271699</phone>
    <phone_ext>5576</phone_ext>
    <email>Zongan.Chen@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lin, PhD</last_name>
      <phone>021-23271699</phone>
      <phone_ext>5576</phone_ext>
      <email>linxiaoxi@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Chen, PhD</last_name>
      <phone>021-23271699</phone>
      <phone_ext>5576</phone_ext>
      <email>Zongan.chen@qq.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 2, 2019</study_first_submitted>
  <study_first_submitted_qc>February 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>July 19, 2020</last_update_submitted>
  <last_update_submitted_qc>July 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</investigator_affiliation>
    <investigator_full_name>XiaoXi Lin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Tension Reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

